世界のセフェピムAPI産業:成長傾向・競合分析2019-2025

【英語タイトル】Global Cefepime API Industry Research Report, Growth Trends and Competitive Analysis 2019-2025

QYResearchが出版した調査資料(QYR20FB07279)・商品コード:QYR20FB07279
・発行会社(調査会社):QYResearch
・発行日:2019年10月(※2024年版があります。お問い合わせください)
・ページ数:118
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:化学・材料
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD5,600 ⇒換算¥828,800見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD8,400 ⇒換算¥1,243,200見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD11,200 ⇒換算¥1,657,600見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
※本調査レポートでは、世界のセフェピムAPI市場について調査・分析し、市場規模、市場動向、市場予測(~2025年)、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。セフェピムAPIの種類別には、セフェピム(L-アルギニン含有)、セフェピム(L-アルギニンなし)に、用途別には、セフェピム注射、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。

・調査レポートの概要
・グローバル成長傾向・産業動向
・企業別市場シェア
・セフェピムAPIの種類別市場規模:セフェピム(L-アルギニン含有)、セフェピム(L-アルギニンなし)
・セフェピムAPIの用途別市場規模:セフェピム注射、その他
・セフェピムAPIの地域別市場規模:北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ
・主要企業のプロフィール:Berr Chem、ACS Dobfar、Sterile India、Nectar Lifesciences、Kopran、Orchid Pharma、Qilu Pharmaceutial、Hangzhou Viwa、Guangzhou Pi & Pi Biotech
・市場規模予測2019-2025:生産量
・市場規模予測2019-2025:消費量
・バリューチェーン・販売チャネル分析
・市場機会・課題分析
...
【レポートの概要】

The molecular formula is C19H24N6O5S2, and CAS number is 88040-23-7.The Cefepime API market was valued at xx Million US$ in 2018 and is projected to reach xx Million US$ by 2025, at a CAGR of xx% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Cefepime API.

This study focuses on the production side and consumption side of Cefepime API, presents the global Cefepime API market size by manufacturers, regions, type and application, history breakdown data from 2014 to 2019, and forecast to 2025.
In terms of production side, this report researches the Cefepime API capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and product type.
In terms of consumption side, this report focuses on the consumption of Cefepime API by regions and application. The key regions like North America, Europe, Asia-Pacific, Central & South America, Middle East and Africa etc.

This report includes the following manufacturers; we can also add the other companies as you want.
Berr Chem
ACS Dobfar
Sterile India
Nectar Lifesciences
Kopran
Orchid Pharma
Qilu Pharmaceutial
Hangzhou Viwa
Guangzhou Pi & Pi Biotech

Market Segment by Product Type
Cefepime with L-Arginine
Cefepime without L-Arginine

Market Segment by Application
Cefepime Injection
Other

Key Regions split in this report:
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa

The study objectives are:
To analyze and research the global Cefepime API status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Cefepime API manufacturers, capacity, production, revenue, market share, and recent development.
To split the breakdown data by regions, type, manufacturers and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Cefepime API are as follows:
History Year: 2014-2019
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Cefepime API Market Size Growth Rate by Type
1.3.2 Cefepime with L-Arginine
1.3.3 Cefepime without L-Arginine
1.4 Market Segment by Application
1.4.1 Global Cefepime API Market Share by Application (2019-2025)
1.4.2 Cefepime Injection
1.4.3 Other
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Production and Capacity Analysis
2.1.1 Global Cefepime API Production Value 2014-2025
2.1.2 Global Cefepime API Production 2014-2025
2.1.3 Global Cefepime API Capacity 2014-2025
2.1.4 Global Cefepime API Marketing Pricing and Trends
2.2 Key Producers Growth Rate (CAGR) 2019-2025
2.2.1 Global Cefepime API Market Size CAGR of Key Regions
2.2.2 Global Cefepime API Market Share of Key Regions
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers

3 Market Share by Manufacturers
3.1 Capacity and Production by Manufacturers
3.1.1 Global Cefepime API Capacity by Manufacturers
3.1.2 Global Cefepime API Production by Manufacturers
3.2 Revenue by Manufacturers
3.2.1 Cefepime API Revenue by Manufacturers (2014-2019)
3.2.2 Cefepime API Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Cefepime API Market Concentration Ratio (CR5 and HHI)
3.3 Cefepime API Price by Manufacturers
3.4 Key Manufacturers Cefepime API Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Cefepime API Market
3.6 Key Manufacturers Cefepime API Product Offered
3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Production and Production Value for Each Type
4.1.1 Cefepime with L-Arginine Production and Production Value (2014-2019)
4.1.2 Cefepime without L-Arginine Production and Production Value (2014-2019)
4.2 Global Cefepime API Production Market Share by Type
4.3 Global Cefepime API Production Value Market Share by Type
4.4 Cefepime API Ex-factory Price by Type

5 Market Size by Application
5.1 Overview
5.2 Global Cefepime API Consumption by Application

6 Production by Regions
6.1 Global Cefepime API Production (History Data) by Regions 2014-2019
6.2 Global Cefepime API Production Value (History Data) by Regions
6.3 North America
6.3.1 North AmericaCefepime API Production Growth Rate 2014-2019
6.3.2 North America Cefepime API Production Value Growth Rate 2014-2019
6.3.3 Key Players in North America
6.3.4 North America Cefepime API Import & Export
6.4 Europe
6.4.1 Europe Cefepime API Production Growth Rate 2014-2019
6.4.2 Europe Cefepime API Production Value Growth Rate 2014-2019
6.4.3 Key Players in Europe
6.4.4 Europe Cefepime API Import & Export
6.5 China
6.5.1 China Cefepime API Production Growth Rate 2014-2019
6.5.2 China Cefepime API Production Value Growth Rate 2014-2019
6.5.3 Key Players in China
6.5.4 China Cefepime API Import & Export
6.6 Japan
6.6.1 Japan Cefepime API Production Growth Rate 2014-2019
6.6.2 Japan Cefepime API Production Value Growth Rate 2014-2019
6.6.3 Key Players in Japan
6.6.4 Japan Cefepime API Import & Export

7 Cefepime API Consumption by Regions
7.1 Global Cefepime API Consumption (History Data) by Regions
7.2 North America
7.2.1 North America Cefepime API Consumption by Type
7.2.2 North America Cefepime API Consumption by Application
7.2.3 North America Cefepime API Consumption by Countries
7.2.4 United States
7.2.5 Canada
7.2.6 Mexico
7.3 Europe
7.3.1 Europe Cefepime API Consumption by Type
7.3.2 Europe Cefepime API Consumption by Application
7.3.3 Europe Cefepime API Consumption by Countries
7.3.4 Germany
7.3.5 France
7.3.6 UK
7.3.7 Italy
7.3.8 Russia
7.4 Asia Pacific
7.4.1 Asia Pacific Cefepime API Consumption by Type
7.4.2 Asia Pacific Cefepime API Consumption by Application
7.4.3 Asia Pacific Cefepime API Consumption by Regions
7.4.4 China
7.4.5 Japan
7.4.6 South Korea
7.4.7 India
7.4.8 Australia
7.4.9 Indonesia
7.4.10 Thailand
7.4.11 Malaysia
7.4.12 Philippines
7.4.13 Vietnam
7.5 Central & South America
7.5.1 Central & South America Cefepime API Consumption by Type
7.5.2 Central & South America Cefepime API Consumption by Application
7.5.3 Central & South America Cefepime API Consumption by Countries
7.5.4 Brazil
7.6 Middle East and Africa
7.6.1 Middle East and Africa Cefepime API Consumption by Type
7.6.2 Middle East and Africa Cefepime API Consumption by Application
7.6.3 Central & South America Cefepime API Consumption by Countries
7.6.4 Turkey
7.6.5 GCC Countries
7.6.6 Egypt
7.6.7 South Africa

8 Company Profiles
8.1 Berr Chem
8.1.1 Berr Chem Company Details
8.1.2 Company Description and Business Overview
8.1.3 Production and Revenue of Cefepime API
8.1.4 Cefepime API Product Introduction
8.1.5 Berr Chem Recent Development
8.2 ACS Dobfar
8.2.1 ACS Dobfar Company Details
8.2.2 Company Description and Business Overview
8.2.3 Production and Revenue of Cefepime API
8.2.4 Cefepime API Product Introduction
8.2.5 ACS Dobfar Recent Development
8.3 Sterile India
8.3.1 Sterile India Company Details
8.3.2 Company Description and Business Overview
8.3.3 Production and Revenue of Cefepime API
8.3.4 Cefepime API Product Introduction
8.3.5 Sterile India Recent Development
8.4 Nectar Lifesciences
8.4.1 Nectar Lifesciences Company Details
8.4.2 Company Description and Business Overview
8.4.3 Production and Revenue of Cefepime API
8.4.4 Cefepime API Product Introduction
8.4.5 Nectar Lifesciences Recent Development
8.5 Kopran
8.5.1 Kopran Company Details
8.5.2 Company Description and Business Overview
8.5.3 Production and Revenue of Cefepime API
8.5.4 Cefepime API Product Introduction
8.5.5 Kopran Recent Development
8.6 Orchid Pharma
8.6.1 Orchid Pharma Company Details
8.6.2 Company Description and Business Overview
8.6.3 Production and Revenue of Cefepime API
8.6.4 Cefepime API Product Introduction
8.6.5 Orchid Pharma Recent Development
8.7 Qilu Pharmaceutial
8.7.1 Qilu Pharmaceutial Company Details
8.7.2 Company Description and Business Overview
8.7.3 Production and Revenue of Cefepime API
8.7.4 Cefepime API Product Introduction
8.7.5 Qilu Pharmaceutial Recent Development
8.8 Hangzhou Viwa
8.8.1 Hangzhou Viwa Company Details
8.8.2 Company Description and Business Overview
8.8.3 Production and Revenue of Cefepime API
8.8.4 Cefepime API Product Introduction
8.8.5 Hangzhou Viwa Recent Development
8.9 Guangzhou Pi & Pi Biotech
8.9.1 Guangzhou Pi & Pi Biotech Company Details
8.9.2 Company Description and Business Overview
8.9.3 Production and Revenue of Cefepime API
8.9.4 Cefepime API Product Introduction
8.9.5 Guangzhou Pi & Pi Biotech Recent Development

9 Market Forecast: Production Side
9.1 Production and Production Value Forecast
9.1.1 Global Cefepime API Capacity, Production Forecast 2019-2025
9.1.2 Global Cefepime API Production Value Forecast 2019-2025
9.2 Cefepime API Production and Production Value Forecast by Regions
9.2.1 Global Cefepime API Production Value Forecast by Regions
9.2.2 Global Cefepime API Production Forecast by Regions
9.3 Cefepime API Key Producers Forecast
9.3.1 North America
9.3.2 Europe
9.3.3 China
9.3.4 Japan
9.4 Forecast by Type
9.4.1 Global Cefepime API Production Forecast by Type
9.4.2 Global Cefepime API Production Value Forecast by Type

10 Market Forecast: Consumption Side
10.1 Consumption Forecast by Application
10.2 Cefepime API Consumption Forecast by Regions
10.3 North America Market Consumption Forecast
10.3.1 North America Cefepime API Consumption Forecast by Countries 2019-2025
10.3.2 United States
10.3.3 Canada
10.3.4 Mexico
10.4 Europe Market Consumption Forecast
10.4.1 Europe Cefepime API Consumption Forecast by Countries 2019-2025
10.4.2 France
10.4.3 UK
10.4.4 Italy
10.4.5 Russia
10.5 Asia Pacific Market Consumption Forecast
10.5.1 Asia Pacific Cefepime API Consumption Forecast by Regions 2019-2025
10.5.2 Japan
10.5.3 South Korea
10.5.4 India
10.5.5 Australia
10.5.6 Indonesia
10.5.7 Thailand
10.5.8 Malaysia
10.5.9 Philippines
10.5.10 Vietnam
10.6 Central & South America Market Consumption Forecast
10.6.1 Central & South America Cefepime API Consumption Forecast by Country 2019-2025
10.7 Middle East and Africa Market Consumption Forecast
10.7.1 Middle East and Africa Cefepime API Consumption Forecast by Countries 2019-2025
10.7.2 GCC Countries
10.7.3 Egypt
10.7.4 South Africa

11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Cefepime API Sales Channels
11.2.2 Cefepime API Distributors
11.3 Cefepime API Customers

12 Opportunities & Challenges, Threat and Affecting Factors
12.1 Market Opportunities
12.2 Market Challenges
12.3 Porter’s Five Forces Analysis

13 Key Findings

14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer



【掲載企業】

Berr Chem、ACS Dobfar、Sterile India、Nectar Lifesciences、Kopran、Orchid Pharma、Qilu Pharmaceutial、Hangzhou Viwa、Guangzhou Pi & Pi Biotech

★調査レポート[世界のセフェピムAPI産業:成長傾向・競合分析2019-2025] (コード:QYR20FB07279)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のセフェピムAPI産業:成長傾向・競合分析2019-2025]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆